The Most Accurate Analyst Speaks Out Again This Weekend
Source: Global Market Report
Michael Harnett, the Chief Investment Officer of Bank of America—reputed as Wall Street’s most accurate analyst—released his market briefing this week. The most notable part of this report isn’t a single conclusion, but rather a few “contrasts.”
1) First contrast: Indexes are strong, but capital is exiting
According to BofA data, over the past week: $55 billion flowed into cash, $29.1 billion into bonds, $13.9 billion flowed out of stocks; U.S. equities saw $17.2 billion in outflows, the largest since March. Crypto experienced $2 billion in outflows, gold saw $3 billion in outflows for the seventh consecutive week. Therefore, this is not an indiscriminate bull market, but a market characterized by “rising prices with concurrent risk reduction.”
2) Second contrast: Outflows from stocks overall, but continued inflows into tech
U.S. stocks saw $17.2 billion in outflows overall, but there was a $14.3 billion inflow into tech stocks, possibly hitting a record for tech inflows since the start of this year. This shows the market isn’t refraining from buying stocks; instead, investors are only buying the narrow group of stocks they have confidence in.
3) Third contrast: Weak non-farm payrolls, but profits may be strong
Although the June non-farm payrolls data was weak, corporate profits for 2026 may be very strong. If weakening employment arises purely from an economic downturn, then the stock market is at risk; but if weaker employment partly stems from productivity gains and improved corporate efficiency, then the market may not be in danger and profit margins could even continue to improve.
4) Fourth contrast: Gold surges, but capital continues to exit
Gold has been rising continuously, surpassing $4,100, but BofA data shows gold funds have been in outflow for seven straight weeks. The lack of capital confirmation behind gold’s rally makes it susceptible to short-term fluctuations.
Additionally, the Bank of America Bull & Bear Indicator has risen to 9.5, close to historical highs and worthy of attention. However, this does not mean a “crash is imminent”—historically, after the indicator triggers a sell signal, global equity markets have on average declined 2%-3% over the subsequent 2-3 months, with a hit rate of around 60%, and the maximum drawdown can reach 15%-20%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

